發表文章
Galvanic Spa Demo with pre-treat and treatment gel.
2009年6月9日 星期二
Galvanic Spa Hair Treatment Demonstration
Hair and scalp treatment demonstration -- 3 to 4 times a week.
Galvanic Spa Spot treatment for Tru Face Line Corrector
Galvanic Spa Spot treatment and Tru Face Line Corrector are prefect match for correcting lines and winkles.
Tru Face Line Corrector features revolutionary pro-collagen peptides that help soften moderate to deep lines around your mouth, eyes, and forehead. Medical science has recently discovered that peptides have the ability to send age-reversing signals to collagen-producing cells, promoting younger-looking skin. Tru Face Line Corrector offers a targeted approach to help the most aggressive signs of aging in just four weeks. Gentle and safe for all skin types.
Tru Face Line Corrector的五胜肽是膠原蛋白的前驅物，細小的分子能深入肌膚細胞，刺激肌膚的支撐組織-膠原蛋白及彈力蛋白的合成，讓鬆弛、產生皺紋的肌膚重現彈力緊實！
早晚使用，短短二至四週便能讓眼角、額頭、嘴角及唇部因乾燥，動態表情形成的細紋和老化造成的中度至深度皺紋均獲得改善，臨床實驗更證明，連續使用六個月，抗皺功效能夠持續地大幅改善!
Experience enhanced results with the Galvanic Spa® II Spot Treatment Conductor. This ergonomically designed conductor head features a smooth, oval-shaped treatment node that centralizes surface contact area, allowing for better contact with the skin and helping to deliver a more concentrated treatment. Recommend to use it morning and night, or right after facial treatment.
可搭配 Galvanic 離子導入美容儀，早晚局部使用於需要抗皺的部位!
Tru Face Line Corrector features revolutionary pro-collagen peptides that help soften moderate to deep lines around your mouth, eyes, and forehead. Medical science has recently discovered that peptides have the ability to send age-reversing signals to collagen-producing cells, promoting younger-looking skin. Tru Face Line Corrector offers a targeted approach to help the most aggressive signs of aging in just four weeks. Gentle and safe for all skin types.
Tru Face Line Corrector的五胜肽是膠原蛋白的前驅物，細小的分子能深入肌膚細胞，刺激肌膚的支撐組織-膠原蛋白及彈力蛋白的合成，讓鬆弛、產生皺紋的肌膚重現彈力緊實！
早晚使用，短短二至四週便能讓眼角、額頭、嘴角及唇部因乾燥，動態表情形成的細紋和老化造成的中度至深度皺紋均獲得改善，臨床實驗更證明，連續使用六個月，抗皺功效能夠持續地大幅改善!
Experience enhanced results with the Galvanic Spa® II Spot Treatment Conductor. This ergonomically designed conductor head features a smooth, oval-shaped treatment node that centralizes surface contact area, allowing for better contact with the skin and helping to deliver a more concentrated treatment. Recommend to use it morning and night, or right after facial treatment.
可搭配 Galvanic 離子導入美容儀，早晚局部使用於需要抗皺的部位!
Galvanic Spa Body Treatment
Galvanic Spa Body Treatment step by step, with body shaping gel, and Dermatic Effects Body Contouring Lotion
AgeLoc Science on Aging
What is ArNox? AgeLoc is the solution to arNox that damaging and aging the skin.
AgeLOC Science on Aging - For more funny videos, click here
AgeLOC Science on Aging - For more funny videos, click here
2009年6月6日 星期六
arNox Article in Health News Digest.com (Apr 12, 2009)
Guest Columnist
Author: Zoe D. Draelos, M.D., Editor in Chief, Journal of Cosmetic Dermatology Last Updated: Apr 23, 2009 - 8:29:17 PM
Have You Ever Wondered Why Some People Look Younger Than Their Actual Age?By Zoe D. Draelos, M.D., Editor in Chief, Journal of Cosmetic Dermatology
Apr 12, 2009 - 9:23:15 AM
(HealthNewsDigest.com) - Are you destined to age at the same rate as your mother? After all, you’ve stayed out of the sun and haven’t picked up smoking – both major culprits for environment aging that cause those dreaded age spots and discoloration. And you’re long past making those funny faces given mom’s advice that your face may just stay that way, helping you to avoid those line and wrinkles that come from mechanical aging. But what about biological aging – the things that age you from the inside out?
Scientists have long believed that biological aging results from changes – perhaps linked to hormones or genes – within the body, and it is particularly noticeable in the appearance of your skin. However, until recently, little was known about the actual sources of aging and if they can be slowed.
arNOX Identified as a Source of Biological Aging
Over the last decade, researchers at Purdue University made considerable progress in elucidating NOX (NADH oxidase) proteins. For example, normal, or constitutive, NOX (cNOX) and tumor NOX (tNOX) were characterized and specific inhibitors for tNOX protein have been identified(1). During this work to further the understanding of NOX proteins, a third, very unique superoxide-generating NOX was observed. A key characteristic of this protein was that its activity increased with advanced age, and thus it was dubbed ‘age-related NOX’ or arNOX.
Classified as an ECTO-NOX protein, arNOX enzymes are external cell-surface located and are capable of being shed into circulation. arNOX has been found in cells and fluids tested, including the keratinocytes, fibroblasts, saliva, serum, perspiration and urine. Unlike other NOX proteins, which carry out four electron transfers to molecular oxygen to form water, arNOX creates the free radical superoxide. Superoxide leads to the formation of H2O2 and other reactive oxygen species capable of damaging circulating lipoproteins, adjacent cells and components of the skin’s extracellular matrix, such as collagen and elastin. It is speculated that over time the local production of free radicals in the skin could damage the components of the skin, eventually contributing to visible signs of aging in the skin.
arNOX Increases with Age
arNOX activity has been shown to increase with age starting between 35 and 45 years of age. Research presented at International Investigative Dermatology (May 2008, Kyoto, Japan) found that arNOX activity in tissue samples was positively correlated to age, independent of environmental exposure(2). arNOX activity levels were collected from saliva, serum, sun-protected and unprotected dermis, and sun-protected and unprotected epidermis (punch biopsies). Across all tissue samples, arNOX activity was positively correlated with age. Younger individuals (around 30 years) had little or no arNOX activity and the activity levels of this enzyme appear highest between the ages of 55 to 65.
The Appearance of Aging is Linked to arNOX
In another study that was presented at the 25th International Federation of the Societies of Cosmetic Chemists Congress (October 2008, Barcelona, Spain) a correlation was identified between arNOX activity levels and an individual’s appearance(3). Women with higher arNOX activity appeared to be an average of seven years older than their actual chronological age; whereas, women with lower arNOX activity appeared to be an average of seven years younger than their chronological age.
Preventing the Visible Signs of Aging
Medical research and technology is moving beyond effectively addressing disease symptoms to identifying root causes. This trend is being applied commercially in new anti-aging therapies, particularly for skin care. The demonstrated correlation between arNOX activity levels and age and appearance is an exciting breakthrough in understanding a source of biological aging. For the first time, rather than simply addressing the signs and symptoms of aging after they occur, a biological source of aging can be targeted. Limiting the production of superoxide from arNOX may prove to be a superior anti-aging therapy because it prevents the actual formation of free radicals at their source, thus mitigating their damage. Traditional therapies focus on neutralizing existing free radicals, as well as repairing damage that has already occurred. This new understanding of biological aging and its effect on skin appearance opens new doors for anti-aging skin research.
REFERENCES
1. NOX Technologies, Inc. Ecto-NOX Proteins. Retrieved 17 February 2009 from http://www.noxtechnologies.com/ectonox.html.
2. Kern, D., Draelos, Z.D., Morré, D.M., and Morré, D.J. Age-related NADH Oxidase (arNOX) Activity of Epidermal Punch Biopsies Correlate with Subject Age and arNOX Activities of Serum and Saliva. Supplement to the Journal of Investigative Dermatology, April 2008; 128(1), S57.
3. Rehmus, WE, Kern, DG, Janjua, R, Knaggs, HE, Morré, DM, Morré, DJ. (October 2008). A Randomized Pilot Study Of the Relationship Between arNOX Levels and Appearance of Skin Aging in Healthy Women. Poster session presented at the 25th International Federation of Societies of Cosmetic Congress, Barcelona Spain.
http://www.healthnewsdigest.com/
Author: Zoe D. Draelos, M.D., Editor in Chief, Journal of Cosmetic Dermatology Last Updated: Apr 23, 2009 - 8:29:17 PM
Have You Ever Wondered Why Some People Look Younger Than Their Actual Age?By Zoe D. Draelos, M.D., Editor in Chief, Journal of Cosmetic Dermatology
Apr 12, 2009 - 9:23:15 AM
(HealthNewsDigest.com) - Are you destined to age at the same rate as your mother? After all, you’ve stayed out of the sun and haven’t picked up smoking – both major culprits for environment aging that cause those dreaded age spots and discoloration. And you’re long past making those funny faces given mom’s advice that your face may just stay that way, helping you to avoid those line and wrinkles that come from mechanical aging. But what about biological aging – the things that age you from the inside out?
Scientists have long believed that biological aging results from changes – perhaps linked to hormones or genes – within the body, and it is particularly noticeable in the appearance of your skin. However, until recently, little was known about the actual sources of aging and if they can be slowed.
arNOX Identified as a Source of Biological Aging
Over the last decade, researchers at Purdue University made considerable progress in elucidating NOX (NADH oxidase) proteins. For example, normal, or constitutive, NOX (cNOX) and tumor NOX (tNOX) were characterized and specific inhibitors for tNOX protein have been identified(1). During this work to further the understanding of NOX proteins, a third, very unique superoxide-generating NOX was observed. A key characteristic of this protein was that its activity increased with advanced age, and thus it was dubbed ‘age-related NOX’ or arNOX.
Classified as an ECTO-NOX protein, arNOX enzymes are external cell-surface located and are capable of being shed into circulation. arNOX has been found in cells and fluids tested, including the keratinocytes, fibroblasts, saliva, serum, perspiration and urine. Unlike other NOX proteins, which carry out four electron transfers to molecular oxygen to form water, arNOX creates the free radical superoxide. Superoxide leads to the formation of H2O2 and other reactive oxygen species capable of damaging circulating lipoproteins, adjacent cells and components of the skin’s extracellular matrix, such as collagen and elastin. It is speculated that over time the local production of free radicals in the skin could damage the components of the skin, eventually contributing to visible signs of aging in the skin.
arNOX Increases with Age
arNOX activity has been shown to increase with age starting between 35 and 45 years of age. Research presented at International Investigative Dermatology (May 2008, Kyoto, Japan) found that arNOX activity in tissue samples was positively correlated to age, independent of environmental exposure(2). arNOX activity levels were collected from saliva, serum, sun-protected and unprotected dermis, and sun-protected and unprotected epidermis (punch biopsies). Across all tissue samples, arNOX activity was positively correlated with age. Younger individuals (around 30 years) had little or no arNOX activity and the activity levels of this enzyme appear highest between the ages of 55 to 65.
The Appearance of Aging is Linked to arNOX
In another study that was presented at the 25th International Federation of the Societies of Cosmetic Chemists Congress (October 2008, Barcelona, Spain) a correlation was identified between arNOX activity levels and an individual’s appearance(3). Women with higher arNOX activity appeared to be an average of seven years older than their actual chronological age; whereas, women with lower arNOX activity appeared to be an average of seven years younger than their chronological age.
Preventing the Visible Signs of Aging
Medical research and technology is moving beyond effectively addressing disease symptoms to identifying root causes. This trend is being applied commercially in new anti-aging therapies, particularly for skin care. The demonstrated correlation between arNOX activity levels and age and appearance is an exciting breakthrough in understanding a source of biological aging. For the first time, rather than simply addressing the signs and symptoms of aging after they occur, a biological source of aging can be targeted. Limiting the production of superoxide from arNOX may prove to be a superior anti-aging therapy because it prevents the actual formation of free radicals at their source, thus mitigating their damage. Traditional therapies focus on neutralizing existing free radicals, as well as repairing damage that has already occurred. This new understanding of biological aging and its effect on skin appearance opens new doors for anti-aging skin research.
REFERENCES
1. NOX Technologies, Inc. Ecto-NOX Proteins. Retrieved 17 February 2009 from http://www.noxtechnologies.com/ectonox.html.
2. Kern, D., Draelos, Z.D., Morré, D.M., and Morré, D.J. Age-related NADH Oxidase (arNOX) Activity of Epidermal Punch Biopsies Correlate with Subject Age and arNOX Activities of Serum and Saliva. Supplement to the Journal of Investigative Dermatology, April 2008; 128(1), S57.
3. Rehmus, WE, Kern, DG, Janjua, R, Knaggs, HE, Morré, DM, Morré, DJ. (October 2008). A Randomized Pilot Study Of the Relationship Between arNOX Levels and Appearance of Skin Aging in Healthy Women. Poster session presented at the 25th International Federation of Societies of Cosmetic Congress, Barcelona Spain.
http://www.healthnewsdigest.com/
Botox .....(New Warning)
By Lisa Richwine
WASHINGTON (Reuters) - Allergan Inc's wrinkle-smoother Botox and similar injections must carry a strong warning about potentially deadly complications if the product spreads in the body, U.S. regulators said on Thursday.
The move follows reports of deaths and hospitalizations in adults and children treated with botulinum toxin for medical conditions, health officials said.
"Botulinum products have benefits but also can cause serious problems so it's important that anyone who administers or receives these products understand the risks involved," Dr. Ellis Unger, acting deputy director of the Food and Drug Administration office that evaluates Botox, told reporters.
No definitive reports of serious harm have been seen when the injections are given at approved doses for cosmetic purposes, such as smoothing wrinkles between the eyebrows, Unger said.
Allergan shares fell 2.6 percent to $46.07 in afternoon trading on the New York Stock Exchange. Botox is a blockbuster product with 2008 sales topping $1.3 billion.
Botulinum toxin can relax or paralyze muscles and is used to smooth wrinkles and to treat conditions ranging from neck spasms to underarm sweating.
In some cases, the toxin can spread to other parts of the body. Possible complications include muscle weakness, trouble breathing or talking, blurry vision and loss of bladder control, the FDA said.
A warning about the complications must be highlighted in a "black box," the strongest type for prescription drugs, the FDA said. It applies to the three approved botulinum toxin products -- Botox; Myobloc from Solstice Neurosciences Inc; and Medicis Pharmaceutical Corp and Ipsen's Dysport.
The makers of Dysport announced the product's approval earlier on Thursday and said the FDA had requested the boxed warning.
Most reports of harm in children involved treatment for cerebral palsy, an unapproved use, the FDA said.
The majority of problems seen in adults followed use of the products to treat spasticity, which is not approved, and neck spasms known as cervical dystonia.
The FDA said it could not attribute any of the deaths in adults to botulinum toxin because the patients also had complications from other conditions.
Allergan said in a statement the company would work with the FDA to update the label for Botox. An official at Solstice Neurosciences could not immediately be reached.
The FDA said doctors will be required to hand out patient-friendly guides explaining the risks. The agency also warned doctors not to interchange the botulinum products.
(Additional reporting by Susan Heavey)
(Editing by Tim Dobbyn, Bernard Orr)
訂閱：
文章 (Atom)